Divalproex Sodium Tablet, Extended Release
Product Images NDC 68180-261
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68180-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 2 (1638e85a 579b 4286 8f77 49f9e6c88488 02)
Image 3 (1638e85a 579b 4286 8f77 49f9e6c88488 03)
Image 4 (1638e85a 579b 4286 8f77 49f9e6c88488 04)
Image (9f0c730e 9756 4a9a 9277 B4ef5ca07604 201 1)
Image (1fc9a662 2c99 4c65 B31c Ebee40f357aa 232 1)
250 mg-100 Pack (1638e85a 579b 4286 8f77 49f9e6c88488 05)
Image 6 (1638e85a 579b 4286 8f77 49f9e6c88488 06)
500 mg- 100 Pack (1638e85a 579b 4286 8f77 49f9e6c88488 07)
500 mg (500 pack)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.